Edgewise Therapeutics, Inc.EWTXNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-9.97%
↑ 26% above average
Average (22q)
-13.52%
Historical baseline
Range
High:7.94%
Low:-74.14%
Volatility
-606.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -9.97% |
| Q2 2025 | 7.29% |
| Q1 2025 | -0.92% |
| Q4 2024 | -12.63% |
| Q3 2024 | -6.10% |
| Q2 2024 | -9.65% |
| Q1 2024 | -2.63% |
| Q4 2023 | -14.97% |
| Q3 2023 | -16.23% |
| Q2 2023 | 1.42% |
| Q1 2023 | -16.42% |
| Q4 2022 | -20.90% |
| Q3 2022 | -10.74% |
| Q2 2022 | -11.23% |
| Q1 2022 | -15.63% |
| Q4 2021 | 1.94% |
| Q3 2021 | -25.01% |
| Q2 2021 | -52.54% |
| Q1 2021 | -8.09% |
| Q4 2020 | -74.14% |
| Q3 2020 | 7.94% |
| Q2 2020 | -21.83% |
| Q1 2020 | 0.00% |